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ABSTRACT 
A simple, accurate rapid and precise RP-HPLC method has been developed and validated for determination of Ondansetron hydrochloride in bulk drug. The 
RP-HPLC separation was achieved on hypersil C18 column (216 mm, 4.6 mm, 5µm) using mobile phase methanol: acetonitrile (50:50 v/v) at flow rate of 1.2 
ml/min at ambient temperature. The retention times were 2.6 min. for Ondansetron hydrochloride.Calibration plots were linear over the concentration range 
10-50µg/ml. Quantification was achieved with photodiode array detection at 216 nm over the concentration range of 10-50 µg/ml. The method was validated 
statistically and applied successfully for the determination of Ondansetron hydrocloride. Validation studies revealed that method is specific, rapid, reliable, and 
reproducible. The high recovery and low relative  standard  deviation  confirm  the  suitability of  the  method  for the routine  determination of  Ondansetron 
hydrochloride in bulk drug. 
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INTRODUCTION 
Ondansetron hydrochloride (ONDA)1, 2, 3, 9-tetrahydro-9-
methyl-3-[(  2-methyl-1H-imidazol-1-yl]-4H-cabbazol-4-one, 
monohydrochloride,  dihydrate.  It  represents  the  class  of 
selective 5HT3 antagonists which is commonly employed as 
anti-emetic  drug  associated  with  cancer  chemotherapy
  1-5, 
radiotherapy or anesthesia.
 6,7. Literature survey revealed that 
very  few  analytical  methods  have  been  reported  for  the 
estimation  of  Ondansetron  hydrochloride  in  combination 
which  includes  HPLC,  HPTLC
  8-12,  and  also 
spectrophotometric method are reported
13. Due to the marked 
polarity  of  the  molecule  and  the  relatively  low  water 
solubility,  reported  methods  for  the  assay  of  Ondansetron 
hydrochloride  are,  mostly,  reversed-phase  HPLC  using 
nitrile,  octylsilyl  and  phenyl  silica  stationary    phases  and 
mixtures of polar solvents as mobile phases
14-17. 
MATERIALS AND METHODS   
All  the  reagents  used  were  of  HPLC  grade  and  analytical 
grade  and  were  purchased  from  Merck  Chemicals,  India. 
Reference  standard  of  Ondansetron  hydrochloride  was 
supplied  as  gift  sample  from  Sun  Pharmaceutical 
Laboratories Limited, Mumbai with purity of 99.987%. 
Chromatographic system and condition: 
A Younglin (LC -2010
TH –Liquid Chromatograph) equipped 
with PDA detector. Promesil C18 ((250 mm, 4.6 mm, 5µm) 
column and LC software were used. The mobile phase used 
was  methanol :  acetonitrile  (50:50  v/v)  which  was  filtered 
through  nylon  0.45  µm  membrane  filter  and  degassed  by 
ultrasonication  for  15  min.  The  flow  rate  was  1.2ml/min. 
Detection was monitored at 216 nm and injection volume was 
20  µl.  All  the  experiment  were  performed  at  ambient 
temperature. 
  Standard  solution  and  calibration  graphs  for 
chromatographic measurement: 
Stock  standard  solutions  were  prepared  by  dissolving 
separately 10mg of Ondansetron hydrochloride in 10 ml of 
methanol. The standard calibration solutions were prepared 
by appropriate dilution of the stock solution with methanol to 
reach  a  concentration  range  of  10-50  µg/ml.  The 
chromatographed  under the  optimized  conditions  described 
above. The peak area was plotted against the corresponding 
concentrations to obtain the calibration graphs. 
  Sample preparation 
Twenty  tablet  contents  were  accurately  weighed,  and  their 
mean weight was determined and they were mixed and finely 
powered.  A  portion  equivalent  to  about  one  tablet  was 
accurately weighed and transferred in to a 100 ml volumetric 
flask containing 50 ml methanol, sonicated for 30 min and 
diluted  to  100  ml  methanol.  The  resulting  solution  was 
centrifuged at 3000 rpm for 5 min. supernatant was taken and 
after suitable dilution the sample solution was then filtered 
using 0.45 µm filter. The original stock solution was further 
diluted  to  get  sample  solution  of  drug  concentration  of  90 
µg/ml. A 20 µl volume of sample solution was injected in to 
HPLC, six times. The peak area was measured at 216 nm and 
amount of Ondansetron hydrochloride were determined using 
related linear regression equation.  
RESULT AND DISCUSSION  
Linearity of the method was investigated by serially diluting 
the working standard to give a concentration range of 10-50 
µm/ml and 20 µl from this was injected. The flow rate was 
maintained at 1.2 ml/min. temperature of column was kept 
ambient  and  the  effluent  was  monitored  at  216  nm. 
Calibration curve was constructed by plotting concentration 
against  peak area.  The  method  was  validated  for  linearity, 
precision, accuracy, specificity, limit of detection and limit of 
quantification as per ICH guidelines.  
Assay  of  tablets  of  Ondansetron  hydrochloride  were 
performed. Twenty tablets of each company of strength 4 mg 
were weighed and ground to a fine powder. A quantity  of 
tablet  powder  equivalent  to  4  mg  of  Ondansetron 
hydrochloride  was  transferred  to  10  ml  volumetric  flask, 
dissolved and diluted with acetonitrile and methanol mixture 
to obtain 1 mg/ml. The solution was sonicated for 15 minute 
and filtered through 0.45 µm membrane filter. The solution 
was  further diluted to obtain concentration 10 µg/ml. Peak 
area of the above prepared tablet solutions of Ondansetron 
hydrochloride  were  measured  by  using  above  mentioned 
chromatographic conditions and the amount of Ondansetron 
hydrochloride were found from regression equation. Alam Imran et al. IRJP 2012, 3 (2) 
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To  optimize  the  HPLC  parameters,  several  mobile  phase 
compositions  were  tried.  Various  mobile  phases  having 
different ratios of methanol, water and acetonitrile were tried. 
Drug was retained in mobile phase consisting of methanol: 
water (60: 40 v/v) and methanol: acetonitrile (50: 50 v/v). In 
methanol: acetonotrile (50: 50 v/v) tailing in the peak was 
observed.  Good  peak  symmetry  and  satisfactory  retention 
time was obtained with mobile phase consisting of methanol: 
acetonitrile  (50:50  v/v).  Quantification  was  achieved  with 
PDA detection at 216 nm based on peak area. The retention 
time of Ondansetron hydrochloride obtained was 2.60±0.132 
(table 1) 
The linear regression date showed a good linear relationship 
over the concentration range of 10-50 µg/ml as summarized 
in Table 3. 
The  limit  of  detection  (LOD)  and  the  limit  of 
quantification(LOQ) of the drug were found by scanning the 
solution of Ondansetron hydrochloride having different lower 
concentrations and the LOD and LOQ were found to be 1.7 
and 5.26 µg/ml indicates that method is sensitive (Table 5). 
The  intraday  and  interday  precision  were  determined  by 
analyzing standard solution of Ondansetron hydrochloride at 
three different concentration levels (6, 8, 10 µg/ml). The % 
RSD  for  intraday  and  interday  precision  was  found  to  be 
0.30% and 0.48% respectively which indicate that method is 
precise (Table 5). Repeatability of the method was studied by 
injecting 10 µg/ml solution of Ondansetron hydrochloride for 
six  times  and  peak  area  was  measured  and  %  RSD  was 
calculated which was found to be 0.195 shows repeatability 
of  the  method  (Table  5).  Accuracy  of  the  method  was 
evaluated by standard addition method in which appropriate 
portion of stock solutions of Ondansetron hydrochloride were 
spiked into blank placebo matrix to produce concentrations of 
80  100  and  120%  of  theoretical  concentration.  The  mean 
recovery of spiked samples obtained was in range of 99.96 to 
100.36 reveals no interference of excipients and shows that 
method is accurate. (Table4). The proposed validated method 
was  successfully  applied  to  determine  Ondansetron 
hydrochloride  in  bulk  drug  and  tablet  form.  The  results 
obtained  for  tablet  of  Ondansetron  hydochloride  were 
comparable  with  the  corresponding  labeled  amounts  (4 
mg/tab) (table 4). Robustness of the method was estimated by 
changing the mobile phase composition (3±3), wavelength ±1 
nm, injection  volume (20±2µl), column temperature (40±3
0) 
and RSD values  for all these changes calculated were less 
than 2 indicate that proposed method is robust. 
The  proposed  RP-HPLC  method  was  accurate,  precise, 
sensitive and rapid. The method also can be extended for the 
routine analysis of Ondansetron hydrochloride in bulk drug 
and tablet dosage form. 
 
 
 
 
CONCLUSION  
It is thus concluded that the proposed method is new, simple, 
cost effective, accurate, safe, free from pollution and precise 
and can be successfully employed in the routine analysis of 
drug.  It  was  successfully  validated  in  terms  of  system 
suitability,  linearity,  range,  precision,  accuracy,  specificity, 
LOD, LOQ, repeatability and robustness in accordance with 
ICH  guidelines.  The  proposed  method  shall  prove  equally 
effective  to  analyze  Ondansetron  hydrochloride  in  the 
corresponding  drug  sample  and  may  prove  to  be  of  great 
importance in pharmaceutical analysis. 
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TABLE 1: HPLC INSTRUMENTATION AND CHROMATOGRAPHIC CONDITIONS FOR ONDANSETRON HYDROCHLORIDE 
Parameters  Description 
Instrument  A HPLC instrument (Younglin  series)  with Model Acme-9000 
Column  Promosil C-18, (250 mm, 4.6 mm, 5µm) 
Mobile Phase  Different mobile phase used for Trial 1 to 6 
Flow Rate  1.2 ml/minute 
Detection wavelength  216 nm 
Injection Volume  20mL 
Run Time  10 minutes Alam Imran et al. IRJP 2012, 3 (2) 
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TABLE-2: SYSTEM SUITABILITY TEST PARAMETERS 
Parameters                                                           RP-HPLC method 
Retention time, min                                                                   2.6 
Tailing factor                                                                             0.81 
Asymmetry factor                   1.25 
Theoretical plates                                                                       43264 
Resolution                                                                                  10.2 
 
TABLE 3: LINEARITY PARAMETERS FOR ESTIMATION OF ONDANSETRON HYDROCHLORIDE (N=6) 
Parameters  Ondansetron  hydrochloride 
Linearity range µg/ml  10-50 
r
2±SD  0.998±0.36 
Slope±SD  0.57±0.21 
Intercept±SD  124.2±0.17 
 
TABLE 4: RESULTS OF ACCURACY STUDIES OF ONDANSETRON HYDROCHLORIDE 
Label claim 
mg/tablet 
Amount added 
(%) 
Total amount added 
(mg) 
Amount recovered 
(mg) 
% Recovery±SD  %RSD 
Ond.Hcl (4)  80  7.2  7.12  99.96±0.30  0.31 
  100  8.0  7.81  99.77±0.41  0.40 
  120  8.8  8.92  100.36±0.52  0.51 
n=6, SD: standard deviation, % RSD: Relative standard deviation 
 
TABLE-5: REGRESSION CHARACTERISTICS AND VALIDATION PARAMETER 
Sr. No.  Parameter  Value 
1.  λmax (nm)  216 
2.  Linearity range  10– 50µg/ml 
3.  Correlation coefficient (r
2)  0.998 
4.  Regression equation  Y=0.57X+124.2 
5.  Intercept (a)  124.2 
6.  Slope (b)  0.57 
7.  Limit of detection (LOD μg/ml)  1.7 
8.  Limit of quantification(LOQ μg/ml)  5.26 
9.  Accuracy (%)  99.96-100.36% 
10.  Repeatability (RSD, %, n=6)  0.195
 
11.  Precision (RSD, %), Interday (n=6)  0.30% 
12.  Intraday (n=6)  0.48% 
 
 
FIG.1: CHEMICAL STRUCTURE OF ONDANSETRON HYDROCHLORIDE 
 
 
FIG.2: REPRESENTIVE CHROMATOGRAMS OF STANDARD   SOLUTION OF ONDANSETRON HYDROCHLORIDE. 
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